Shoulder joint injury
Conditions
Interventions
group ITM:Inject 30ml of 0.375% ropivacaine hydrochloride
group C:Inject 30ml of 0.9% physiological saline
Sponsors
Chongqing University Three Gorges Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients undergoing elective shoulder arthroscopic surgery (2) Age greater than or equal to 18 years old (3) ASA grading I to III
Exclusion criteria
Exclusion criteria: (1) Patients and their families refuse to participate in the trial (2) Individuals with preoperative cognitive impairment (3) Individuals with severe organ dysfunction (4) Infected person at the puncture site of nerve block (5) Individuals with severe coagulation disorders (6) Individuals who are allergic to the drugs used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-15 recovery quality score on the 7th day after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| QoR-15 recovery quality score on the 3th day after surgery;QoR-15 recovery quality score on the 30th day after surgery;Total amount of analgesic medication used during 30 days after surgery;Time required for initial analgesic medication;Adverse reactions of analgesic drugs;VAS pain score;length of hospital stay;Hospitalization Costs;patient satisfaction;The incidence of complications duriong 30 days after surgery; | — |
Countries
China
Contacts
Public ContactZeng Xing
Chongqing University Three Gorges Hospital
Outcome results
None listed